|
Office Location:
Office Phone:
Office Fax:
Mailing Address: |
Francis H. Shen, MDThe goal of Dr. Shen's practice to provide care for patients with spinal pathology through a combination of both operative and nonoperative means. When surgery is required Dr. Shen combines both traditional open surgical techniques with cutting-edge minimal invasive techniques individualized to the patient's specific spine pathology. Furthermore, Dr. Shen's laboratory is improving the future of patient care by applying tissue engineering principles to solve clinically relevant problems. He is dedicated to advancing the future of spine surgery by training not only post-doctorate research fellows, but also to training the next generation of clinical spine surgeons as well.
|
|
|
Appointments: |
Assistant Professor of Orthopaedic Surgery |
|
|
Specialty: |
Orthopedic Surgery |
|
|
Subspecialty: |
Spinal Surgery |
|
|
Special Expertise: |
Surgery of the cervical, thoracic, and lumbosacral spine including anterior and posterior approaches. Management of degenerative conditions, spinal deformity, trauma, tumors, and infections of the spine. In addition to traditional open surgery, Dr. Shen also specializes in minimally invasive surgery, image guided spine surgery, and microsurgery. |
|
|
Awards: |
2009 Scoliosis Research Society Traveling Fellowship |
|
|
Education: |
1987-1992 Undergraduate, University of Michigan, BS in Biomedical Engineering |
|
|
Residency: |
1996 - 1997 General Surgery Internship, University of Virginia |
|
|
Certification: |
Orthopaedic Surgery |
|
|
State License: |
Illinois, Virginia |
|
|
Research Description: |
Research initiative can be divided into either basic science research or clinical research studies. The Shen Laboratory uses tissue engineering principles to develop techniques for the management of spinal fusions and treatment of intervertebral disc degeneration. Also actively using novel animal models developed in his laboratory for the treatment of isolated metastatic spinal tumors and osteoporosis. Clinical research focuses on the use of osteoinductive (bone producing) proteins for generating spinal fusions and on developing innovative techniques for complex spinal reconstructions, particularly after large tumor resections and high-energy sacral-pelvic trauma. Involved with applying clinical techniques for the novel uses for minimally invasive spine surgery, image-guided spine surgery, and robotic-assisted spine surgery. |
|
|
Clinical Trials: |
NovoSeven (F7SPIN-2180). Role: Principle Investigator. Title: Evaluating the safety of activated recombinant Factor VII in spinal surgery. Goal: This randomized, double-blinded, placebo-controlled, multicenter, dose-escalation study evaluated the safety of activated recombinant Factor VII in spinal surgery. |
|
| Publications |
||